1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Wet Age-Related Macular Degeneration (Wet AMD)
        1.2.3 Dry Age-Related Macular Degeneration (Dry AMD)
    1.3 Market by Age
        1.3.1 Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Age, 2017 VS 2021 VS 2028
        1.3.2 Above 75 Years
        1.3.3 Above 60 Years
        1.3.4 Above 40 Years
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Wet Age Related Macular Degeneration (AMD) Market Perspective (2017-2028)
    2.2 Wet Age Related Macular Degeneration (AMD) Growth Trends by Region
        2.2.1 Wet Age Related Macular Degeneration (AMD) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Wet Age Related Macular Degeneration (AMD) Historic Market Size by Region (2017-2022)
        2.2.3 Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Region (2023-2028)
    2.3 Wet Age Related Macular Degeneration (AMD) Market Dynamics
        2.3.1 Wet Age Related Macular Degeneration (AMD) Industry Trends
        2.3.2 Wet Age Related Macular Degeneration (AMD) Market Drivers
        2.3.3 Wet Age Related Macular Degeneration (AMD) Market Challenges
        2.3.4 Wet Age Related Macular Degeneration (AMD) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Wet Age Related Macular Degeneration (AMD) Players by Revenue
        3.1.1 Global Top Wet Age Related Macular Degeneration (AMD) Players by Revenue (2017-2022)
        3.1.2 Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Players (2017-2022)
    3.2 Global Wet Age Related Macular Degeneration (AMD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Wet Age Related Macular Degeneration (AMD) Revenue
    3.4 Global Wet Age Related Macular Degeneration (AMD) Market Concentration Ratio
        3.4.1 Global Wet Age Related Macular Degeneration (AMD) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Wet Age Related Macular Degeneration (AMD) Revenue in 2021
    3.5 Wet Age Related Macular Degeneration (AMD) Key Players Head office and Area Served
    3.6 Key Players Wet Age Related Macular Degeneration (AMD) Product Solution and Service
    3.7 Date of Enter into Wet Age Related Macular Degeneration (AMD) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Wet Age Related Macular Degeneration (AMD) Breakdown Data by Type
    4.1 Global Wet Age Related Macular Degeneration (AMD) Historic Market Size by Type (2017-2022)
    4.2 Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2023-2028)
5 Wet Age Related Macular Degeneration (AMD) Breakdown Data by Age
    5.1 Global Wet Age Related Macular Degeneration (AMD) Historic Market Size by Age (2017-2022)
    5.2 Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Age (2023-2028)
6 North America
    6.1 North America Wet Age Related Macular Degeneration (AMD) Market Size (2017-2028)
    6.2 North America Wet Age Related Macular Degeneration (AMD) Market Size by Type
        6.2.1 North America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022)
        6.2.2 North America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028)
        6.2.3 North America Wet Age Related Macular Degeneration (AMD) Market Share by Type (2017-2028)
    6.3 North America Wet Age Related Macular Degeneration (AMD) Market Size by Age
        6.3.1 North America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2017-2022)
        6.3.2 North America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2023-2028)
        6.3.3 North America Wet Age Related Macular Degeneration (AMD) Market Share by Age (2017-2028)
    6.4 North America Wet Age Related Macular Degeneration (AMD) Market Size by Country
        6.4.1 North America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022)
        6.4.2 North America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Wet Age Related Macular Degeneration (AMD) Market Size (2017-2028)
    7.2 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type
        7.2.1 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022)
        7.2.2 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028)
        7.2.3 Europe Wet Age Related Macular Degeneration (AMD) Market Share by Type (2017-2028)
    7.3 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Age
        7.3.1 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Age (2017-2022)
        7.3.2 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Age (2023-2028)
        7.3.3 Europe Wet Age Related Macular Degeneration (AMD) Market Share by Age (2017-2028)
    7.4 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Country
        7.4.1 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022)
        7.4.2 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size (2017-2028)
    8.2 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Type
        8.2.1 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Share by Type (2017-2028)
    8.3 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Age
        8.3.1 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Age (2017-2022)
        8.3.2 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Age (2023-2028)
        8.3.3 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Share by Age (2017-2028)
    8.4 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Region
        8.4.1 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Wet Age Related Macular Degeneration (AMD) Market Size (2017-2028)
    9.2 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Type
        9.2.1 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022)
        9.2.2 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028)
        9.2.3 Latin America Wet Age Related Macular Degeneration (AMD) Market Share by Type (2017-2028)
    9.3 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Age
        9.3.1 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2017-2022)
        9.3.2 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2023-2028)
        9.3.3 Latin America Wet Age Related Macular Degeneration (AMD) Market Share by Age (2017-2028)
    9.4 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Country
        9.4.1 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022)
        9.4.2 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size (2017-2028)
    10.2 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Type
        10.2.1 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Share by Type (2017-2028)
    10.3 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Age
        10.3.1 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Age (2017-2022)
        10.3.2 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Age (2023-2028)
        10.3.3 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Share by Age (2017-2028)
    10.4 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Country
        10.4.1 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Novartis International (Switzerland)
        11.1.1 Novartis International (Switzerland) Company Details
        11.1.2 Novartis International (Switzerland) Business Overview
        11.1.3 Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Introduction
        11.1.4 Novartis International (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.1.5 Novartis International (Switzerland) Recent Developments
    11.2 Bayer (Germany)
        11.2.1 Bayer (Germany) Company Details
        11.2.2 Bayer (Germany) Business Overview
        11.2.3 Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Introduction
        11.2.4 Bayer (Germany) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.2.5 Bayer (Germany) Recent Developments
    11.3 Acucela (US)
        11.3.1 Acucela (US) Company Details
        11.3.2 Acucela (US) Business Overview
        11.3.3 Acucela (US) Wet Age Related Macular Degeneration (AMD) Introduction
        11.3.4 Acucela (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.3.5 Acucela (US) Recent Developments
    11.4 Neurotech Pharmaceuticals (US)
        11.4.1 Neurotech Pharmaceuticals (US) Company Details
        11.4.2 Neurotech Pharmaceuticals (US) Business Overview
        11.4.3 Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Introduction
        11.4.4 Neurotech Pharmaceuticals (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.4.5 Neurotech Pharmaceuticals (US) Recent Developments
    11.5 Ophthotech (US)
        11.5.1 Ophthotech (US) Company Details
        11.5.2 Ophthotech (US) Business Overview
        11.5.3 Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Introduction
        11.5.4 Ophthotech (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.5.5 Ophthotech (US) Recent Developments
    11.6 GlaxoSmithKline (US)
        11.6.1 GlaxoSmithKline (US) Company Details
        11.6.2 GlaxoSmithKline (US) Business Overview
        11.6.3 GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Introduction
        11.6.4 GlaxoSmithKline (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.6.5 GlaxoSmithKline (US) Recent Developments
    11.7 Alimera Sciences (US)
        11.7.1 Alimera Sciences (US) Company Details
        11.7.2 Alimera Sciences (US) Business Overview
        11.7.3 Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Introduction
        11.7.4 Alimera Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.7.5 Alimera Sciences (US) Recent Developments
    11.8 StemCell (Canada)
        11.8.1 StemCell (Canada) Company Details
        11.8.2 StemCell (Canada) Business Overview
        11.8.3 StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Introduction
        11.8.4 StemCell (Canada) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.8.5 StemCell (Canada) Recent Developments
    11.9 F. Hoffmann-La Roche (Switzerland)
        11.9.1 F. Hoffmann-La Roche (Switzerland) Company Details
        11.9.2 F. Hoffmann-La Roche (Switzerland) Business Overview
        11.9.3 F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Introduction
        11.9.4 F. Hoffmann-La Roche (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.9.5 F. Hoffmann-La Roche (Switzerland) Recent Developments
    11.10 Regeneron Pharmaceutical (US)
        11.10.1 Regeneron Pharmaceutical (US) Company Details
        11.10.2 Regeneron Pharmaceutical (US) Business Overview
        11.10.3 Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Introduction
        11.10.4 Regeneron Pharmaceutical (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.10.5 Regeneron Pharmaceutical (US) Recent Developments
    11.11 Allergan (Ireland)
        11.11.1 Allergan (Ireland) Company Details
        11.11.2 Allergan (Ireland) Business Overview
        11.11.3 Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Introduction
        11.11.4 Allergan (Ireland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.11.5 Allergan (Ireland) Recent Developments
    11.12 Adverum Biotechnologies (US)
        11.12.1 Adverum Biotechnologies (US) Company Details
        11.12.2 Adverum Biotechnologies (US) Business Overview
        11.12.3 Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Introduction
        11.12.4 Adverum Biotechnologies (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.12.5 Adverum Biotechnologies (US) Recent Developments
    11.13 Gilead Sciences (US)
        11.13.1 Gilead Sciences (US) Company Details
        11.13.2 Gilead Sciences (US) Business Overview
        11.13.3 Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Introduction
        11.13.4 Gilead Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.13.5 Gilead Sciences (US) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Wet Age-Related Macular Degeneration (Wet AMD)
    Table 3. Key Players of Dry Age-Related Macular Degeneration (Dry AMD)
    Table 4. Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Age (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Wet Age Related Macular Degeneration (AMD) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Wet Age Related Macular Degeneration (AMD) Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Wet Age Related Macular Degeneration (AMD) Market Share by Region (2017-2022)
    Table 8. Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Wet Age Related Macular Degeneration (AMD) Market Share by Region (2023-2028)
    Table 10. Wet Age Related Macular Degeneration (AMD) Market Trends
    Table 11. Wet Age Related Macular Degeneration (AMD) Market Drivers
    Table 12. Wet Age Related Macular Degeneration (AMD) Market Challenges
    Table 13. Wet Age Related Macular Degeneration (AMD) Market Restraints
    Table 14. Global Wet Age Related Macular Degeneration (AMD) Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Players (2017-2022)
    Table 16. Global Top Wet Age Related Macular Degeneration (AMD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wet Age Related Macular Degeneration (AMD) as of 2021)
    Table 17. Ranking of Global Top Wet Age Related Macular Degeneration (AMD) Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Wet Age Related Macular Degeneration (AMD) Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Wet Age Related Macular Degeneration (AMD) Product Solution and Service
    Table 21. Date of Enter into Wet Age Related Macular Degeneration (AMD) Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Wet Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2017-2022)
    Table 25. Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2023-2028)
    Table 27. Global Wet Age Related Macular Degeneration (AMD) Market Size by Age (2017-2022) & (US$ Million)
    Table 28. Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Age (2017-2022)
    Table 29. Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Age (2023-2028) & (US$ Million)
    Table 30. Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Age (2023-2028)
    Table 31. North America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2017-2022) & (US$ Million)
    Table 34. North America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2023-2028) & (US$ Million)
    Table 35. North America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Age (2017-2022) & (US$ Million)
    Table 40. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Age (2023-2028) & (US$ Million)
    Table 41. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Age (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Age (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2017-2022) & (US$ Million)
    Table 52. Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2023-2028) & (US$ Million)
    Table 53. Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Size by Age (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Size by Age (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Novartis International (Switzerland) Company Details
    Table 62. Novartis International (Switzerland) Business Overview
    Table 63. Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Product
    Table 64. Novartis International (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 65. Novartis International (Switzerland) Recent Developments
    Table 66. Bayer (Germany) Company Details
    Table 67. Bayer (Germany) Business Overview
    Table 68. Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Product
    Table 69. Bayer (Germany) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 70. Bayer (Germany) Recent Developments
    Table 71. Acucela (US) Company Details
    Table 72. Acucela (US) Business Overview
    Table 73. Acucela (US) Wet Age Related Macular Degeneration (AMD) Product
    Table 74. Acucela (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 75. Acucela (US) Recent Developments
    Table 76. Neurotech Pharmaceuticals (US) Company Details
    Table 77. Neurotech Pharmaceuticals (US) Business Overview
    Table 78. Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Product
    Table 79. Neurotech Pharmaceuticals (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 80. Neurotech Pharmaceuticals (US) Recent Developments
    Table 81. Ophthotech (US) Company Details
    Table 82. Ophthotech (US) Business Overview
    Table 83. Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Product
    Table 84. Ophthotech (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 85. Ophthotech (US) Recent Developments
    Table 86. GlaxoSmithKline (US) Company Details
    Table 87. GlaxoSmithKline (US) Business Overview
    Table 88. GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Product
    Table 89. GlaxoSmithKline (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 90. GlaxoSmithKline (US) Recent Developments
    Table 91. Alimera Sciences (US) Company Details
    Table 92. Alimera Sciences (US) Business Overview
    Table 93. Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Product
    Table 94. Alimera Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 95. Alimera Sciences (US) Recent Developments
    Table 96. StemCell (Canada) Company Details
    Table 97. StemCell (Canada) Business Overview
    Table 98. StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Product
    Table 99. StemCell (Canada) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 100. StemCell (Canada) Recent Developments
    Table 101. F. Hoffmann-La Roche (Switzerland) Company Details
    Table 102. F. Hoffmann-La Roche (Switzerland) Business Overview
    Table 103. F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Product
    Table 104. F. Hoffmann-La Roche (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 105. F. Hoffmann-La Roche (Switzerland) Recent Developments
    Table 106. Regeneron Pharmaceutical (US) Company Details
    Table 107. Regeneron Pharmaceutical (US) Business Overview
    Table 108. Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Product
    Table 109. Regeneron Pharmaceutical (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 110. Regeneron Pharmaceutical (US) Recent Developments
    Table 111. Allergan (Ireland) Company Details
    Table 112. Allergan (Ireland) Business Overview
    Table 113. Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Product
    Table 114. Allergan (Ireland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 115. Allergan (Ireland) Recent Developments
    Table 116. Adverum Biotechnologies (US) Company Details
    Table 117. Adverum Biotechnologies (US) Business Overview
    Table 118. Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Product
    Table 119. Adverum Biotechnologies (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 120. Adverum Biotechnologies (US) Recent Developments
    Table 121. Gilead Sciences (US) Company Details
    Table 122. Gilead Sciences (US) Business Overview
    Table 123. Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Product
    Table 124. Gilead Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 125. Gilead Sciences (US) Recent Developments
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Wet Age Related Macular Degeneration (AMD) Market Share by Type: 2021 VS 2028
    Figure 2. Wet Age-Related Macular Degeneration (Wet AMD) Features
    Figure 3. Dry Age-Related Macular Degeneration (Dry AMD) Features
    Figure 4. Global Wet Age Related Macular Degeneration (AMD) Market Share by Age: 2021 VS 2028
    Figure 5. Above 75 Years Case Studies
    Figure 6. Above 60 Years Case Studies
    Figure 7. Above 40 Years Case Studies
    Figure 8. Wet Age Related Macular Degeneration (AMD) Report Years Considered
    Figure 9. Global Wet Age Related Macular Degeneration (AMD) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Wet Age Related Macular Degeneration (AMD) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Wet Age Related Macular Degeneration (AMD) Market Share by Region: 2021 VS 2028
    Figure 12. Global Wet Age Related Macular Degeneration (AMD) Market Share by Players in 2021
    Figure 13. Global Top Wet Age Related Macular Degeneration (AMD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wet Age Related Macular Degeneration (AMD) as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Wet Age Related Macular Degeneration (AMD) Revenue in 2021
    Figure 15. North America Wet Age Related Macular Degeneration (AMD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2017-2028)
    Figure 17. North America Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Age (2017-2028)
    Figure 18. North America Wet Age Related Macular Degeneration (AMD) Market Size Share by Country (2017-2028)
    Figure 19. United States Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Wet Age Related Macular Degeneration (AMD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Age (2017-2028)
    Figure 24. Europe Wet Age Related Macular Degeneration (AMD) Market Size Share by Country (2017-2028)
    Figure 25. Germany Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Age (2017-2028)
    Figure 34. Asia Pacific Wet Age Related Macular Degeneration (AMD) Market Size Share by Region (2017-2028)
    Figure 35. China Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Wet Age Related Macular Degeneration (AMD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Age (2017-2028)
    Figure 44. Latin America Wet Age Related Macular Degeneration (AMD) Market Size Share by Country (2017-2028)
    Figure 45. Mexico Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Age (2017-2028)
    Figure 50. Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Size Share by Country (2017-2028)
    Figure 51. Turkey Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Novartis International (Switzerland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 55. Bayer (Germany) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 56. Acucela (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 57. Neurotech Pharmaceuticals (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 58. Ophthotech (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 59. GlaxoSmithKline (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 60. Alimera Sciences (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 61. StemCell (Canada) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 62. F. Hoffmann-La Roche (Switzerland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 63. Regeneron Pharmaceutical (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 64. Allergan (Ireland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 65. Adverum Biotechnologies (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 66. Gilead Sciences (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed